Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders.
Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders.
复制标题
DOI:
10.1136/gutjnl-2018-316029
复制
发表时间:
2018-08
期刊:
影响因子:
24.5
通讯作者:
Camilleri M
中科院分区:
文献类型:
--
作者:
Waldman SA;Camilleri M
Functional gastrointestinal disorders (FGIDs) and IBDs are two of the most prevalent disorders of the GI tract and consume a significant proportion of healthcare resources. Recent studies have shown that membrane-bound guanylate cyclase-C (GC-C) receptors lining the GI tract may serve as novel therapeutic targets in the treatment of FGIDs and IBDs. GC-C receptor activation by its endogenous paracrine hormones uroguanylin and guanylin, and the resulting intracellular production of its downstream effector cyclic GMP, occurs in a pH-dependent manner and modulates key physiological functions. These include fluid and electrolyte homeostasis, maintenance of the intestinal barrier, anti-inflammatory activity and regulation of epithelial regeneration. Studies of the GC-C paracrine signalling axis have revealed the therapeutic potential of these receptors in treating GI disorders, including chronic idiopathic constipation and irritable bowel syndrome–constipation. This review focuses on the evolving understanding of GC-C function in health and disease, and strategies for translating these principles into new treatments for FGIDs and IBDs.
登录
查看更多内容
影响因子:
3.6
作者:
Brenna Ø;Furnes MW;Munkvold B;Kidd M;Sandvik AK;Gustafsson BI
通讯作者:
Gustafsson BI
影响因子:
9.8
作者:
Chey, William D.;Lembo, Anthony J.;Johnston, Jeffrey M.
通讯作者:
Johnston, Jeffrey M.
影响因子:
158.5
作者:
Fiskerstrand, Torunn;Arshad, Najla;Knappskog, Per M.
通讯作者:
Knappskog, Per M.
影响因子:
29.4
作者:
Foulke-Abel J;In J;Yin J;Zachos NC;Kovbasnjuk O;Estes MK;de Jonge H;Donowitz M
通讯作者:
Donowitz M
DOI:
10.1073/pnas.75.6.2800
发表时间:
1978-01-01
影响因子:
11.1
作者:
FIELD, M;GRAF, LH;SMITH, PL
通讯作者:
SMITH, PL